Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
AstraZeneca
Fish and Richardson
Harvard Business School
Boehringer Ingelheim
Julphar
QuintilesIMS
Healthtrust
Chubb

Generated: May 22, 2018

DrugPatentWatch Database Preview

Eagle Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for EAGLE PHARMS, and when can generic versions of EAGLE PHARMS drugs launch?

EAGLE PHARMS has four approved drugs.

There are twenty-two US patents protecting EAGLE PHARMS drugs. There is one tentative approval on EAGLE PHARMS drugs.

There are ninety patent family members on EAGLE PHARMS drugs in thirty-four countries and three supplementary protection certificates in three countries.

Summary for Eagle Pharms
International Patents:90
US Patents:22
Tradenames:4
Ingredients:4
NDAs:4

Drugs and US Patents for Eagle Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eagle Pharms BENDEKA bendamustine hydrochloride SOLUTION;IV (INFUSION) 208194-001 Dec 7, 2015 RX Yes Yes 8,609,707 ➤ Sign Up Y ➤ Sign Up
Eagle Pharms BENDEKA bendamustine hydrochloride SOLUTION;IV (INFUSION) 208194-001 Dec 7, 2015 RX Yes Yes 9,034,908 ➤ Sign Up ➤ Sign Up
Eagle Pharms RYANODEX dantrolene sodium FOR SUSPENSION;INTRAVENOUS 205579-001 Jul 22, 2014 RX Yes Yes 8,604,072 ➤ Sign Up Y ➤ Sign Up
Eagle Pharms DOCETAXEL docetaxel SOLUTION;IV (INFUSION) 205934-002 Dec 22, 2015 RX No No 9,308,195 ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for EAGLE PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Injection 100 mg/4 mL (25 mg/mL) multiple-dose vials ➤ Subscribe 2017-05-04

Non-Orange Book US Patents for Eagle Pharms

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,789,090 Treatment using dantrolene ➤ Sign Up
9,271,964 Treatment using dantrolene ➤ Sign Up
9,763,880 Non-aqueous taxane formulations and methods of using the same ➤ Sign Up
8,895,756 Bendamustine pharmaceutical compositions ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Supplementary Protection Certificates for Eagle Pharms Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
60002 Netherlands ➤ Sign Up PRODUCT NAME: DOCETAXEL, DESGEWENST IN DE VORM VAN EEN TRIHYDRAAT; REGISTRATION NO/DATE: EU/1/95/002/001 - EU/1/95/002/002 19951127
/2013 Austria ➤ Sign Up PRODUCT NAME: DIMETHOXYDOCETAXEL-ACETONSOLVAT (CABAZITAXEL-ACETONSOLVAT); REGISTRATION NO/DATE: EU/1/11/676/001 20110317
172 Luxembourg ➤ Sign Up PRODUCT NAME: SOLVAT ACETONIQUE DU CABAZITAXEL, OU DESIGNE SOLVAT ACETONIQUE DU DIMETHOXY DOCETAXEL OU SOLVAT ACETONIQUE DU (2R,3S)-3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DE 4-ACETOXY-2A-BENZOYLOXY-5BETA,20-EPOXY-1-HYDROXY-7BETA,10A-DIMETHOXY-9-OXO-TAX-11-ENE-13A-YLE(ACETONATE DU CABAZITAXEL)
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Healthtrust
Daiichi Sankyo
AstraZeneca
Citi
Cipla
Express Scripts
Dow
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.